Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus, Mini-dose Methotrexate and MMF for GVHD Prevention
NCT01951885Phase 3Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Jul 2014
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mycophenolate mofetil in graft-versus-host disease (GVHD), sponsored by Case Comprehensive Cancer Center. Started Jul 2014; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT01951885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01951885.